Table 2 Clinical characteristics of the 158 NMIBC patients under surveillance
Characteristic | Recurrence-free (n = 86) | Recurrence (n = 72) |
|---|---|---|
Age, yrs. | ||
Median | 67 | 66 |
Range | 30–84 | 28–83 |
Sex, no. (%) | ||
Male | 74 (86.1) | 52 (72.2) |
Female | 12 (13.9) | 20 (27.8) |
Smoking History, no. (%) | ||
Current smoker | 25 (29.1) | 12 (16.7) |
Former smoker | 34 (39.5) | 22 (30.6) |
Non-smoker | 26 (30.2) | 35 (48.6) |
Missing | 1 (1.2) | 3 (4.1) |
Recurrence Rate, no. (%) | 72 (45.6) | |
Time to recurrences, mos. | ||
Median/Range | 10/3–24 | |
Follow-up Urine Analyzed, no. | 312 | 113 |
Total Urine Analyzed, no. | 398 | 185 |
Cytology, no. (%) | ||
Negative/Positive/Suspicious | 67 (77.9)/6 (7.0)/2 (2.3) | 50 (69.5)/2 (2.8)/3 (4.1) |
Missing | 11 (12.8) | 17 (23.6) |
Tumor Stage, no. (%) | ||
pTa/pT1/CIS | 62 (72.1)/14 (16.3)/4 (4.6) | 55 (76.4)/11 (15.3)/2 (2.8) |
Other | 6 (7.0) | 4 (5.5) |
Tumor Grade, no. (%) | ||
Low/High | 48 (55.8)/38 (44.2) | 47 (65.3)/25 (34.7) |
Risk Categories, no. (%) | ||
Low/Intermediate/High | 23 (26.7)/25 (29.1)/38 (44.2) | 15 (20.8)/28 (38.9)/29 (40.3) |